术前PI-RADS第2版评分有助于提高临床列线图预测根治性前列腺切除术后盆腔淋巴结转移的准确性
该回顾性研究纳入308例接受多参数磁共振成像及根治性前列腺切除联合盆腔淋巴结清扫的患者,评估PI-RADSv2评分对淋巴结浸润的预测价值。结果显示PI-RADSv2评分是独立预测因子(AUC 80.2%),阈值取5时敏感度90.0%、阴性预测值99.0%;与Briganti和MSKCC列线图联合后AUC分别从75.1%升至86.3%、从79.2%升至87.9%(p≤0.001)。
要点
- 308例中20例(6.5%)存在淋巴结浸润。
- PI-RADSv2评分是淋巴结浸润最准确的预测因子,AUC为80.2%。
- PI-RADSv2评分<5的患者淋巴结浸润风险很低。
核心结论
- PI-RADSv2评分<5的前列腺癌患者淋巴结浸润风险很低;术前PI-RADSv2评分有助于提高临床列线图预测根治性前列腺切除时盆腔淋巴结转移的准确性。
研究设计与样本
- 回顾性识别308例接受多参数磁共振成像及根治性前列腺切除联合盆腔淋巴结清扫的患者,评估临床病理参数与PI-RADSv2评分,行单因素和多因素logistic分析,并用AUC和决策曲线分析评估增量价值。
主要发现
- 总体20例(6.5%)患者存在淋巴结浸润。
- 单因素分析中所有临床病理特征及PI-RADSv2评分均与淋巴结浸润显著相关(p<0.04);多因素分析仅PI-RADSv2评分和阳性穿刺针数百分比为独立显著因素(p≤0.006)。
- PI-RADSv2评分是最准确的预测因子,AUC为80.2%。
- PI-RADSv2评分阈值为5时,敏感度为18/20(90.0%),阴性预测值为203/205(99.0%)。
- PI-RADSv2评分与Briganti列线图联合后AUC从75.1%升至86.3%,与MSKCC列线图联合后AUC从79.2%升至87.9%(p≤0.001);决策曲线分析也显示两种列线图联合PI-RADSv2评分改善了淋巴结浸润的临床风险预测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lymph node invasion (LNI) is a strong adverse prognostic factor in prostate cancer (PCa). The purpose of this study was to evaluate the role of Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) scores for estimating the risk of LN metastasis. The study also aimed to investigate the additional value of PI-RADSv2 scores when used in combination with clinical nomograms for the prediction of LNI in patients with PCa. METHODS: We retrospectively identified 308 patients who underwent multiparametric magnetic resonance imaging (mpMRI) and RP with pelvic lymph node dissection (PLND). Clinicopathological parameters and PI-RADSv2 scores were assessed. Univariate and multivariate logistic analyses were performed. The area under the receiver operating characteristic curves (AUCs) and decision curve analysis (DCA) were generated for assessing the incremental value of PI-RADSv2 scores combined with the Briganti and Memorial Sloan Kettering Cancer Center (MSKCC) nomograms. RESULTS: Overall, 20 (6.5%) patients had LNI. At univariate analysis, all clinicopathological characteristics and PI-RADSv2 scores were significantly associated to LNI (p < 0.04). However, multivariate analysis revealed that only PI-RADSv2 scores and percentage of positive cores were independently significant (p ≤ 0.006). The PI-RADSv2 score was the most accurate predictor (AUC, 80.2%). The threshold of PI-RADSv2 score was 5, which provided high sensitivity (18/20, 90.0%) and negative predictive value (203/205, 99.0%). When PI-RADSv2 scores were combined with Briganti and MSKCC nomograms, the AUC value increased from 75.1 to 86.3% and from 79.2 to 87.9%, respectively (p ≤ 0.001). The DCA also demonstrated that the two nomograms plus PI-RADSv2 scores improved clinical risk prediction of LNI. CONCLUSIONS: The patients with a PI-RADSv2 score <5 were associated with a very low risk of LNI in PCa. Preoperative PI-RADSv2 scores could help improve the accuracy of clinical nomograms for predicting pelvic LN metastasis at radical prostatectomy.
引用
- Huang C, Song G, Wang H, et al. Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy. Prostate Cancer Prostatic Dis. 2019. PMID: 31383954. doi:10.1038/s41391-019-0164-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。